1. Home
  2. PEB vs PGEN Comparison

PEB vs PGEN Comparison

Compare PEB & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

HOLD

Current Price

$14.11

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.11

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEB
PGEN
Founded
2009
1998
Country
United States
United States
Employees
60
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PEB
PGEN
Price
$14.11
$4.11
Analyst Decision
Hold
Buy
Analyst Count
11
5
Target Price
$12.59
$8.33
AVG Volume (30 Days)
2.4M
5.6M
Earning Date
04-28-2026
05-13-2026
Dividend Yield
0.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
N/A
$1,115.92
Revenue Next Year
$2.25
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.56
$1.23
52 Week High
$14.23
$5.47

Technical Indicators

Market Signals
Indicator
PEB
PGEN
Relative Strength Index (RSI) 69.45 56.19
Support Level $10.21 $4.02
Resistance Level N/A $4.43
Average True Range (ATR) 0.34 0.28
MACD 0.11 0.02
Stochastic Oscillator 96.00 76.85

Price Performance

Historical Comparison
PEB
PGEN

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: